Mechanistic and antineoplastic evaluation of taurolidine in the DU145 model of human prostate cancer

Cancer Chemotherapy and Pharmacology

Volumn 54, Issue 3, 2004, Pages 249-258

  Darnowski, James W ^a   Goulette, Frederick A ^a   Cousens, Leslie P ^a   Chatterjee, Devasis ^a   Calabresi, Paul ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Apoptosis; Chemotherapy; Cytochrome c; Prostate cancer; Taurolidine; Xenografts

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLSERINE; TAUROLIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; ENZYME DEGRADATION; FEMALE; HUMAN; HUMAN CELL; IC 50; MITOCHONDRION; MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR CELL LINE; TUMOR GROWTH; TUMOR XENOGRAFT;

EID: 4344566710     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-004-0806-1     Document Type: Article

References (47)

1. Adams JM, Huang DC, Puthalakath H, Bouillet P, Vairo G, Moriishi K, Hausmann G, O'Reilly L, Newton K, Ogilvy S, Bath ML, Print CG, Harris AW, Strasser A, Cory S (1999) Control of apoptosis in hematopoietic cells by the cl-2 family of proteins. Cold Spring Harb Symp Quant Biol 64:351-358
2. Atkinson EA, Barry M, Darmon AJ, Shostak I, Turner PC, Moyer RW, Bleackley RC (1998) Cytotoxic T lymphocyte-assisted suicide. Caspase 3 activation is primarily the result of a direct action of granzyme B. J Biol Chem 273:21261-21266
3. Bantel H, Engels IH, Voelter W, Schulze-Osthoff K, Wesselborg S (1999) Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis. Cancer Res 59:2083-2090
4. Blenkharn JI (1987) The antibacterial and antiendotoxin activity of taurolidine in combination with antibiotics. Surg Res Commun 2:149-155
5. Bossey-Wetzel E, Newmeyer DD, Green DR (1998) Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J 17:37-49
6. Browne MK, Leslie GB, Pfirrmann RW, Brodhuge H (1977) The in vitro and in vivo activity of taurolin against anaerobic pathogenic organisms. Surg Gynecol Obstet 145:842-846
7. Browne MK, Mackenzie M, Doyle PJ (1978) A controlled trial of taurolin in established bacterial peritonitis. Surg Gynecol Obstet 146:721-724
8. Brunetti I, Falcone A, Calabresi P, Goulette FA, Darnowski JW (1990) 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies. Cancer Res 50:4026-4031
9. Budijardjo I, Oliver H, Lutter M, Luo X, Wang X (1999) Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15:269-290
10. Calabresi P, Goulette FA, Darnowski JW (2000) Antineoplastic effects of taurolidine in human tumor cell lines. Proc Am Assoc Cancer Res 41:771
11. Calabresi P, Goulette FA, Darnowski JW (2001) Taurolidine: cytotoxic and mechanistic evaluation of a novel antineoplastic agent. Cancer Res 61:6816-6821
12. DaCosta ML, Redmond HP, Bouchier-Hayes DJ (2001) Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery. J Surg Res 101:111-119
13. Darnowski JW, Handschumacher RE (1985) Tissue-specific enhancement of uridine utilization and 5-fluorouracil therapy in mice by benzylacyclouridine. Cancer Res 45:5364-5368
14. Darnowski JW, Davol PA, Goulette FA (1997) Human recombinant interferon alpha-2a plus 3′-azido-3′-deoxythymidine. Synergistic growth inhibition with evidence of impaired DNA repair in human colon adenocarcinoma cells. Biochem Pharmacol 53:571-580
15. Darnowski JW, Goulette FA, Wagner EF, Simms E, Calabresi P (2001) Taurolidine: a novel, nontoxic, antineoplastic agent that induces apoptosis in androgen-independent DU145 human prostate tumor cells. Proc Am Assoc Cancer Res 42:212
16. Davol PA, Goulette FA, Frackelton AR Jr, Darnowski JW (1996) Modulation of p53 expression by human recombinant interferon-a2a correlates with abrogation of cisplatin resistance in a human melanoma cell line. Cancer Res 56:2522-2526
17. Debatin KM, Poncet D, Kroemer G (2002) Chemotherapy: targeting the mitochondrial cell death pathway. Oncogene 21:8786-8803
18. Erb F, Imbenotte M, Huveene J (1983) Structural investigation of a new organic antimicrobial: taurolidine. Analytical study and application to identification and quantification in biological fluids. Eur J Drug Metabol Pharmacokinet 8:163-173
19. Fulda S, Sievens H, Frieson C, Herr I, Debatin KM (1997) The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res 57:3823-3829
20. Fulda S, Frriesen C, Los M, Scaffidi C, Mier W, Benedict M, Nunez G, Krammer PH, Peter ME, Debatin KM (1997) Botulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res 57:4956-4965
21. Gorman SP, McCafferty DF, Woolfson AD, Junes DS (1987) Reduced adherence of microorganisms to human mucosal epithelial cells following treatment with taurolin, a novel antimicrobial agent. J Appl Bacteriol 62:315-320
22. Green DR, Kroemer G (1998) The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol 8:267-271
23. Han Z, Ribizzi I, Pantazis P, Wyche JH, Darnowski J, Calabresi P (2002) The antibacterial drug taurolidine induces apoptosis by a mitochondrial cytochrome c-dependent mechanism. Anticancer Res 22:1959-1964
24. Hartfield PJ, Bilney AJ, Murray AW (1998) Neurotrophic factors prevent ceramide-induced apoptosis downstream of c-Jun N-terminal kinase activation in PC12 cells. J Neurochem 71:161-169
25. Jacobi CA, Ordemann J, Bohm B, Zieren HU, Sabat R, Muller JM (1997) Inhibition of peritoneal tumor cell growth and implantation in laparoscopic surgery in a rat model. Am J Surg 174:359-363
26. Jacobi CA, Wildbrett P, Volk T, Muller JM (1999) Influence of different gases and intraperitoneal instillation of antiadherent or cytotoxic agents on peritoneal tumor cell growth and implantation with laparoscopic surgery in a rat model. Surg Endosc 13:1021-1025
27. Kasibhatla S, Brunner T, Genestier L, Echeverri F, Mahboubi A, Green DR (1998) DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via activation of NF-KB and AP-1. Mol Cell 1:543-551
28. Knight BI, Skellern GG, Browne MK, Pfirrmann RW (1981) The characterization and quantitation by HPLC (high performance liquid chromatography) of the metabolites of taurolin. Br J Clin Pharmacol 12:439-440
29. Knight BI, Skellern GG, Smail GA, Browne MK, Pfirrmann RW (1983) NMR studies and GC analysis of the antibacterial agent, taurolidine. J Pharm Sci 72:705-707
30. Kuida K (2000) Caspase-9. Int J Biochem Cell Biol 32:121-124
31. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC (1994) Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371:346-347
32. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmed M, Alnemri ES, Wang X (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479-489
33. Magalhaes PJ, Rizzuto R (2001) Mitochondria and calcium homeostasis: a tale of three luminescent proteins. Luminescence 16:67-71
34. McCartney AC, Browne MK (1988) Clinical studies on administration of taurolin in severe sepsis: a preliminary study. Prog Clin Biol Res 272:361-371
35. Moser G, Martin MD (1978) Forty cases of peritonitis treated without antibiotics: the intraperitoneal and intravenous use of taurolin. PRAXIS 67:425-428
36. Muller M, Strand S, Hug H, Heinemann EM, Walczak H, Hoffman WJ, Stremmel W, Krammer PH, Galle PR (1997) Drug-induced apoptosis in hepatoma cells is mediated by CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest 99:403-413
37. Newmeyer DD, Ferguson-Miller S (2002) Mitochondria: releasing power for life and unleashing the machineries of death. Cell 112:481-490
38. Petak I, Tillman DM, Harwood FG, Mihalik R, Houghton JA (2000) Fas-dependent and -independent mechanisms of cell death following DNA damage in human colon carcinoma cells. Cancer Res 60:2643-2650
39. Ribizzi I, Darnowski JW, Goulette FA, Sertoli MR, Calabresi P (2000) Amifostine cytotoxicity and induction of apoptosis in a human myelodysplastic cell line. Leuk Res 24:519-525
40. Ribizzi I, Han Z, Darnowski JW, Goulette F, Wagner EF, Calabresi P (2001) Taurolidine: mechanism of action of a novel and safe cytotoxic agent for cancer therapy. Proc Am Assoc Cancer Res 42:212
41. Ribizzi I, Darnowski JW, Goulette FA, Akhtar MS, Chatterjee D, Calabresi P (2002) Taurolidine: preclinical evaluation of a novel, highly selective, agent for bone marrow purging. Bone Marrow Transplant 29:313-319
42. Rizzuto R, Bernardi P, Pozzan T (2000) Mitochondria as all-around players of the calcium game. J Physiol 529:37-47
43. Shrayer DP, Lukoff H, King T, Calabresi P (2003) The effect of taurolidine on adherent and floating subpopulations of melanoma cells. Anticancer Drugs 14:295-303
44. Smulson ME, Pang D, Jung M, Dimtchev A, Chasovskikh S, Spoonde A, Simbulan-Rosenthal C, Rosenthal D, Yakovlev A, Dritschilo A (1998) Irreversible binding of poly (ADP-ribose) polymerase cleavage product to DNA ends revealed by atomic force microscopy: possible role in apoptosis. Cancer Res 58:3496-3498
45. Wei MC, Zong WX, Cheng EH, Linsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Korsmeyer SJ (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292:727-730
46. Wesselborg S, Engels IH, Rossman E, Los M, Schulze-Osthoff K (1999) Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction. Blood 93:3053-3063
47. Zou H, Li X, Wang X (1999) An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 274:11549-11556